Braidwell’s Axonics, Inc. Common Stock AXNX Stock Holding History

Braidwell’s Portfolio AXNX Stock Details AXNX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q4	–	Sell	-354,527	Closed	-$19.9M	–	89
2023 Q3	$19.9M	Sell	354,527 -219,264	-38%	-$12.3M	0.63%	52
2023 Q2	$29M	Buy	573,791 +407,087	+244%	+$21.7M	0.95%	37
2023 Q1	$9.1M	Buy	+166,704	New	+$9.74M	0.3%	68

Other funds holding AXNX

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

CIP

Champlain Investment Partners Burlington, Vermont $3.89B AUM 16.15% 1-Year Est. Return

Bellevue Group Kuesnacht, Switzerland $4.75B AUM 68.58% 1-Year Est. Return

Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return

BAMCO Inc New York $66.6B AUM 7.35% 1-Year Est. Return

Axa Paris, France $91.9M AUM 27.41% 1-Year Est. Return

Loomis, Sayles & Company Boston, Massachusetts $79.8B AUM 16.05% 1-Year Est. Return

HRCM

Hood River Capital Management Palm Beach Gardens, Florida $13.8B AUM 163.97% 1-Year Est. Return

Braidwell's AXNX Position: Q4 2023 in Review

Braidwell sold out of Axonics, Inc. Common Stock (AXNX) in Q4 2023, closing a stake of 354,527 shares — an estimated $19.9M sold.

Braidwell first reported a position in AXNX in Q1 2023 and held it in 3 quarters. The position peaked at $29M in Q2 2023. 229 funds tracked by Wall St. Rank hold AXNX as of Q4 2023.

Braidwell reported no remaining Axonics, Inc. Common Stock position as of Q4 2023 after selling out during the quarter.
Braidwell sold 354,527 Axonics, Inc. Common Stock shares in Q4 2023, an estimated $19.9M.
Braidwell first reported a position in Axonics, Inc. Common Stock in Q1 2023 and held it in 3 quarters.
Braidwell's Axonics, Inc. Common Stock position peaked at $29M in Q2 2023.
229 funds tracked by Wall St. Rank held Axonics, Inc. Common Stock as of Q4 2023.

Based on Braidwell's 13F filing for Q4 2023, filed 14 Feb 2024.